Daclatasvir, terapia più breve contro i genotipi 2 e 3 dell'epatite C [Gastro]
Pharmastar Italy,
Il regime di trattamento a base di daclatasvir in combinazione con interferone alfa-2a (Peg-IFN alfa- 2a) e ribavirina si è…
Daclatasvir Plus Peginterferon and Ribavirin Is Noninferior to Peginterferon and Ribavirin Alone, and Reduces the Duration of Treatment for HCV Genotype 2 or 3 Infection
Overview of attention for article published in Gastroenterology, October 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (91st percentile)
-
High Attention Score compared to outputs of the same age and source (81st percentile)
Mentioned by
- news
- 1 news outlet
- policy
- 2 policy sources
- 2 X users
- f1000
- 1 research highlight platform
Readers on
- mendeley
- 76 Mendeley